Patrick J. Lustman, PhD
Professor of Psychiatry
Washington University School of Medicine
St. Louis, Missouri

Dr. Patrick J. Lustman is Professor of Psychiatry and Co-director of the Center for Mind Body Research at Washington University School of Medicine. He received his undergraduate degree from the University of Illinois and his doctorate from Michigan State University. After completing a post-doctoral fellowship at Washington University, he joined the faculty there. He is board certified as a Diplomate in Health Psychology by American Board of Professional Psychologists.

In 1983 Dr. Lustman received a New Investigator Award from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to study psychiatric disorders in diabetes; NIH funding of this work continues to the present time. He has served on the editorial boards of Diabetes Care and Clinical Diabetes and has been a member of the Research Policy Committee and the Grant Review Panel of the American Diabetes Association.

Dr. Lustman's research focuses on the interaction of psychiatric and medical illness. His studies have established the importance of depression in diabetes—not only are the odds of depression doubled in diabetes, depression is also associated with hyperglycemia and an increased risk for diabetic complications. In addition, he has conducted numerous clinical trials on the safety and efficacy of antidepressant treatment in patients diabetes which clarify the relationship of antidepressant treatment to medical outcome in this group. This body of work is the product of a longstanding collaboration with Kenneth Freedland, Ph.D., and with Ray Clouse, M.D., who also serves as the Center Co-director.

Contact Information:
Phone: (314) 362-2621
Fax: (314) 362-2422
Email: lustmanp@wustl.edu


Depression in Adults with Diabetes

GI Disorders
Psychiatric Comorbidity with Functional GI Disorders
Central Interactions with Gastrointestinal Motility Disorders

Stress and Mental Health
Improving Depression Treatment Outcomes with an Insulin-Sensitizing Agent